Diagnostic Investigation of Sudden Cardiac Event Risk (DISCERN)
Identifying Markers That Predict Ventricular Arrhythmia Risk
Sponsor: CardioDx
Listed as NCT00500708, this observational or N/A phase trial focuses on Arrhythmia and CVD and remains completed. Sponsored by CardioDx, it has been updated 13 times since 2007, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
▶ Show 8 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Nov 2017 — Apr 2018 [monthly]
Completed NA
-
Oct 2017 — Nov 2017 [monthly]
Completed NA
-
Aug 2017 — Oct 2017 [monthly]
Completed NA
-
Feb 2017 — Aug 2017 [monthly]
Completed NA
Status: Suspended → Completed
-
Jan 2017 — Feb 2017 [monthly]
Suspended NA
First recorded
Jul 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CardioDx
For direct contact, visit the study record on ClinicalTrials.gov .